The impact of novel influenza A (H1N1) after hematopoietic SCT

Bone Marrow Transplantation

Volumn 45, Issue 12, 2010, Pages 1756-1757

  Patel, P ^a   Sweiss, K ^a   Shatavi, S ^a   Peace, D ^a   Clark, N ^b   Rondelli, D ^a  

^a SECTION OF HEMATOLOGY ONCOLOGY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUDARABINE; MELPHALAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSELTAMIVIR; PERAMIVIR; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ANTIGEN DETECTION; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; DISEASE COURSE; DRUG MEGADOSE; DRUG RESPONSE; FATALITY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INTENSIVE CARE; LUNG ASPERGILLOSIS; MALE; MUCORMYCOSIS; PARAINFLUENZA VIRUS 1; PARAINFLUENZA VIRUS INFECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHIZOPUS; TREATMENT RESPONSE; VIRUS DETECTION; VIRUS SHEDDING;

ADULT; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 78650219155     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.57     Document Type: Article

References (8)

1. Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: A review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009; 9: 493-504.
2. Centers for Disease Control and Prevention (CDC). Oseltamivir- resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients-Seattle, Washington, 2009. Morb Mortal Wkly Rep 2009; 58: 893-896.
3. Bastos DA, Rodrigues CA, Patah P, Dias BS, Rocha V, Novis Y. Influenza A H1N1 virus infection in two hematopoietic stem cell transplant recipients. Blood (ASH Annu Meet Abstr) 2009; 114: 480 (abstract 1169).
4. Kharfan-Dabaja MA, Velez A, Richards K, Greene JN, Field T, Sandin R. Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: A potentially catastrophic problem in a vulnerable population. Int J Hematol 2009; 91: 124-127.
5. Casper C, Englund J, Boeckh M. How we treat influenza in patients with hematologic malignancies. Blood 2010; 115: 1331-1342.
6. Ljungman P, Avetisyan G. Influenza vaccination in hematopoietic SCT recipients. Bone Marrow Transplant 2008; 42: 637-641.
7. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: Risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39: 1300-1306.
8. Centers for Disease Control and Prevention (CDC). Antiviral treatment options, including intravenous peramivir, for treatment of influenza in hospitalized patients for the 2009-2010 season. http://www.cdc.gov/H1N1flu/EUA/ peramivir-recommendations.htm (accessed 24 December 2009).